Should angiotensin-converting enzyme inhibitors be used in all patients with coronary artery disease or restricted to those with a history of myocardial infarction or myocardial revascularization?
2009 ◽
Vol 102
(2)
◽
pp. 81-83
◽
2011 ◽
Vol 63
(5)
◽
pp. 1151-1161
◽
2009 ◽
Vol 11
(Suppl E)
◽
pp. E9-E16
◽
2010 ◽
Vol 100
(4)
◽
pp. 327-333
◽
1998 ◽
Vol 32
(7)
◽
pp. 1962-1968
◽
1996 ◽
Vol 10
(S2)
◽
pp. 639-647
◽
2000 ◽
Vol 109
(5)
◽
pp. 371-377
◽